Higher prices for MS drug help drug firm Merck
Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in ...
Huge drug cost disparities seen in health overhaul
Cancer patients could face high costs for medications under President Barack Obama's health care law, industry analysts and advocates warn. Where you ...
IMS: US medicine spending shows rare dip in 2012
Spending on prescription medicines in the U.S. fell for the first time in decades last year, slipping as cash-strapped consumers continued to cut back ...
High hospital bills go public, but will it help?
For the first time, the government is publicly revealing how much hospitals charge, and the differences are astounding: Some bill tens of thousands ...
States fear losing aid for 'uninsurables'
Thousands of people with serious medical problems are in danger of losing coverage under President Barack Obama's health care overhaul because of cost ...
CVS Caremark 1Q profit soars 23 percent
CVS Caremark's first-quarter net income jumped 23 percent to top Wall Street's expectations, as generic drugs continued to improve profitability even ...
Pfizer 1Q profit up, but drugmaker cuts outlook
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a ...
Aetna 1Q profit slips 4 pct, boosts 2013 forecast
Aetna's first-quarter net income fell 4 percent as acquisition-related costs and rising health care expenses more than offset government business ...
Boston victims face huge bills; donations pour in
Cost of amputating a leg? At least $20,000. Cost of an artificial leg? More than $50,000 for the most high-tech models. Cost of an amputee's rehab? ...
US hospitals send hundreds of immigrants back home
Days after they were badly hurt in a car accident, Jacinto Cruz and Jose Rodriguez-Saldana lay unconscious in an Iowa hospital while the American ...
J&J 1Q profit falls 10 pct despite higher sales
Johnson & Johnson's first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and ...
Budget: cover uninsured, trim Medicare, tax cigs
President Barack Obama's new budget offers Medicare cuts to entice Republicans into tax negotiations, while plowing ahead to cover the uninsured next ...
Pentagon struggles with high cost of health care
The loud, insistent calls in Washington to rein in the rising costs of Social Security and Medicare ignore a major and expensive entitlement program ...
India's rejection of drug patent could reverberate
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the ...
Drug maker Novartis loses India patent battle
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that ...
India's top court to deliver Novartis judgment
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies ...
The South: A near-solid block against 'Obamacare'
As more Republicans give in to President Barack Obama's health-care overhaul, an opposition bloc remains across the South, including from governors ...
Study: Health law to raise claims cost 32 percent
A new study finds that insurance companies will have to pay out an average of 32 percent more for medical claims on individual health policies under ...
High court struggles over generic drug delay deals
Supreme Court justices appeared troubled Monday over whether to stop deals between pharmaceutical corporations and their generic drug competitors that ...
Court: Can drug companies pay to delay generics?
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing ...
AstraZeneca reorg to cut 1,600 jobs in US, UK
Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new ...
Insurers warn of overhaul-induced sticker shock
Some Americans could see their insurance bills double next year as the health care overhaul law expands coverage to millions of people. The nation's ...
India rejects Bayer plea against cheap cancer drug
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling ...
Study: No quick savings from workplace wellness
Your bosses want you to eat your broccoli, hit the treadmill and pledge you'll never puff on a cigarette. But a new study raises doubts that workplace ...
Email
US
International
India
Россия
Română
Singapore
South Africa
México
Indonesia
Brasileira
